Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
2
×
archive
biotech
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
europe
europe blog main
europe top stories
indiana blog main
indiana top stories
life sciences
medical
medicine
national blog main
new york blog main
new york top stories
research
slgt2 inhibitor
type 1 diabetes
type 2 diabetes
What
approval
2
×
drug
2
×
fda
2
×
type
2
×
administration
announced
bid
blood
boehringer
brand
called
cancer
diabetes
eli
expand
fallen
fast
food
ingelheim
lilly
marketed
medicine’s
new
patients
rejects
selinexor
short
sold
track
tracked
treatment
xpovio
Language
unset
Current search:
fda
×
drug
×
fda
×
approval
×
type
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@slashgear.com
4 years ago
The FDA just fast-tracked this new blood cancer treatment
